Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Baxter
AstraZeneca
Moodys
McKesson
Colorcon

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Litigation Details for SUMITOMO DAINIPPON PHARMA CO., LTD. v. MACLEODS PHARMACEUTICALS LTD. (D.N.J. 2018)

See Plans and Pricing

« Back to Dashboard

SUMITOMO DAINIPPON PHARMA CO., LTD. v. MACLEODS PHARMACEUTICALS LTD. (D.N.J. 2018)

Docket   Start Trial Date Filed 2018-09-12
Court District Court, D. New Jersey Date Terminated 2019-01-14
Cause 35:271 Patent Infringement Assigned To Stanley R. Chesler
Jury Demand None Referred To Cathy L. Waldor
Parties MACLEODS PHARMA USA, INC.; MACLEODS PHARMACEUTICALS LTD.; SUMITOMO DAINIPPON PHARMA CO., LTD.; SUNOVION PHARMACEUTICALS INC.
Patents 5,532,372; 8,729,085; 8,883,794; 9,174,975; 9,259,423; 9,555,027; 9,815,827; 9,827,242; 9,907,794
Attorneys CHARLES H. CHEVALIER; CHRISTINE A. GADDIS; DAVID E. DELORENZI; GURPREET SINGH WALIA; JOSEPH SCHRAMM , III
Firms Fisherbroyles, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in SUMITOMO DAINIPPON PHARMA CO., LTD. v. MACLEODS PHARMACEUTICALS LTD.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for SUMITOMO DAINIPPON PHARMA CO., LTD. v. MACLEODS PHARMACEUTICALS LTD. (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-09-12 1 with the FDA ten patents for Latuda®. The listed patents are U.S. Patent Nos. 5,532,372, 8,729,085, 8,883,794…United States Patent Nos. 9,815,827 (the “’827 patent”) and 9,907,794 (the “’794 patent”) (collectively…the ’827 patent is attached hereto as Exhibit A. A true and accurate copy of the ’794 patent is attached… U.S. Patent No. 9,815,827 37. The ’827 patent, entitled “Agent for Treatment… ’827 patent. 39. Plaintiff Sunovion is the exclusive licensee to the ’827 patent in the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Dow
Boehringer Ingelheim
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.